Safi K, Pawlicka A, Pradhan B, Sobieraj J, Zhylko A, Struga M
Biomedicines. 2025; 13(2).
PMID: 40002907
PMC: 11852418.
DOI: 10.3390/biomedicines13020494.
Kobayashi S, Kamiya K, Miki T, Yamashita M, Noda T, Ueno K
Ann Surg Oncol. 2024; 31(12):7722-7729.
PMID: 39154156
DOI: 10.1245/s10434-024-16012-2.
Miranda J, Key Wakate Teruya A, Leao Filho H, Lahan-Martins D, Tamura Sttefano Guimaraes C, de Paula Reis Guimaraes V
Abdom Radiol (NY). 2024; 49(12):4437-4462.
PMID: 38896247
DOI: 10.1007/s00261-024-04407-4.
Zhang Z, Li G, Wang Z, Xia F, Zhao N, Nie H
Sci Rep. 2024; 14(1):11987.
PMID: 38796521
PMC: 11127985.
DOI: 10.1038/s41598-024-62887-2.
Puri P, Kumar A, Qaleem M
J Clin Exp Hepatol. 2023; 14(1):101217.
PMID: 38076356
PMC: 10709134.
DOI: 10.1016/j.jceh.2023.07.004.
Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review.
Jang W, Song J
Diagnostics (Basel). 2023; 13(11).
PMID: 37296703
PMC: 10252963.
DOI: 10.3390/diagnostics13111852.
Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study.
Hatano Y, VanWagner L, Carnethon M, Bancks M, Carson A, Lloyd-Jones D
Diabetologia. 2023; 66(7):1235-1246.
PMID: 36941389
PMC: 10286118.
DOI: 10.1007/s00125-023-05903-w.
Investigation of comorbidities of COVID-19 patients with hepatosteatosis using latent class analysis.
Pasin O, Cetin S, Kaya A
Front Public Health. 2022; 10:990848.
PMID: 36249206
PMC: 9558709.
DOI: 10.3389/fpubh.2022.990848.
Liver-Spleen Ratio: Can It Be Used for the Prediction of Coronary Artery Disease?.
Poyraz N, Ozer H, Baloglu I, Kadiyoran C, Yilmaz P, Sertdemir A
Anatol J Cardiol. 2022; 26(10):762-770.
PMID: 35943316
PMC: 9623218.
DOI: 10.5152/AnatolJCardiol.2022.1787.
Risk factor analysis of postoperative pancreatic fistula after distal pancreatectomy, with a focus on pancreas-visceral fat CT value ratio and serrated pancreatic contour.
Maeda K, Kuriyama N, Yuge T, Ito T, Gyoten K, Hayasaki A
BMC Surg. 2022; 22(1):240.
PMID: 35733145
PMC: 9215066.
DOI: 10.1186/s12893-022-01650-8.
Non-invasive diagnosis and staging of non-alcoholic fatty liver disease.
Kechagias S, Ekstedt M, Simonsson C, Nasr P
Hormones (Athens). 2022; 21(3):349-368.
PMID: 35661987
PMC: 9464753.
DOI: 10.1007/s42000-022-00377-8.
Correlation between Transient Elastography (Fibroscan) and Ultrasonographic and Computed Tomographic Grading in Pediatric Nonalcoholic Steatohepatitis.
Lee J, Ko K, Lim J, Cheon E, Song Y, Yoon J
Pediatr Gastroenterol Hepatol Nutr. 2022; 25(3):240-250.
PMID: 35611380
PMC: 9110850.
DOI: 10.5223/pghn.2022.25.3.240.
A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients.
Cioni D, Gabelloni M, Sanguinetti A, De Rosa L, Aringhieri G, Tintori R
Front Oncol. 2022; 12:873524.
PMID: 35574336
PMC: 9093140.
DOI: 10.3389/fonc.2022.873524.
Chest Computed Tomography Is an Efficient Method for Initial Diagnosis of COVID-19: An Observational Study.
Vieira W, Franco K, Dias A, Falcao A, Falcao L, Quaresma J
Front Med (Lausanne). 2022; 9:848656.
PMID: 35492320
PMC: 9039662.
DOI: 10.3389/fmed.2022.848656.
Correlation of Hepatic Steatosis Among Cohabitants Using Hounsfield Unit From Coronary Computed Tomography.
Ali Z, Saeed I, Bybee K, Thompson R, OKeefe J, Shafiq M
Cureus. 2021; 13(9):e17834.
PMID: 34660042
PMC: 8502746.
DOI: 10.7759/cureus.17834.
SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review.
Dwinata M, Putera D, Hasan I, Raharjo M
Clin Exp Hepatol. 2021; 6(4):339-346.
PMID: 33511282
PMC: 7816633.
DOI: 10.5114/ceh.2020.102173.
Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
Ichikawa K, Miyoshi T, Osawa K, Miki T, Toda H, Ejiri K
Cardiovasc Diabetol. 2021; 20(1):8.
PMID: 33413363
PMC: 7791695.
DOI: 10.1186/s12933-020-01192-4.
Quantification of Hepatic Fat Fraction in Patients With Nonalcoholic Fatty Liver Disease: Comparison of Multimaterial Decomposition Algorithm and Fat (Water)-Based Material Decomposition Algorithm Using Single-Source Dual-Energy Computed Tomography.
Zhang Q, Zhao Y, Wu J, Xie L, Chen A, Liu Y
J Comput Assist Tomogr. 2020; 45(1):12-17.
PMID: 33186174
PMC: 7834908.
DOI: 10.1097/RCT.0000000000001112.
Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study.
Parmar K, OReilly D, Valle J, Braun M, Naish J, Williams S
BMJ Open. 2020; 10(9):e027630.
PMID: 32967864
PMC: 7513559.
DOI: 10.1136/bmjopen-2018-027630.
Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease.
Grat K, Grat M, Rowinski O
Biomedicines. 2020; 8(9).
PMID: 32839409
PMC: 7556032.
DOI: 10.3390/biomedicines8090298.